Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct-Nov;60(6):554-558.
doi: 10.1016/j.reval.2020.07.003. Epub 2020 Sep 6.

[Allergic immunotherapy in children and adolescents]

[Article in French]
Affiliations
Review

[Allergic immunotherapy in children and adolescents]

[Article in French]
F Amat et al. Rev Fr Allergol (2009). 2020 Oct-Nov.

Abstract

Specific allergic immunotherapy requires repeated administration of allergens in order to induce clinical and immunological tolerance. This is the only therapy with an aetiological aim that modifies the course of the disease by ensuring remission after the interruption of the procedure. The prevention of new sensitizations by immunotherapy is still under discussion. In this review we will consider the main immunological mechanisms and indications for immunotherapy in children and adolescents.

L’immunothérapie spécifique allergénique nécessite l’administration répétée d’allergènes dans le but de provoquer une tolérance clinique et immunologique. C’est la seule thérapeutique à visée étiologique qui permet de modifier l’évolution de la maladie en assurant une rémission après l’interruption de la procédure. La prévention de nouvelles sensibilisations par l’immunothérapie reste discutée. Nous envisagerons dans cette revue les principaux mécanismes immunologiques et les indications de l’immunothérapie chez l’enfant et l’adolescent.

Keywords: Adolescent; Asthma; Children; Food allergy; Immunotherapy; Rhinitis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mécanismes immunologiques.
Fig. 2
Fig. 2
Terminologie pour les tests de provocation par voie orale d’après Casale et al. .

References

    1. Noon L. Prophylactic inoculation against hay fever. Lancet. 1911;1:1572–1573.
    1. Lowell F.C., Franklin W. A double-blind study of the effectiveness and specificity of injecton therapy in ragweed hay fever. N Engl J Med. 1965;273:675–679. - PubMed
    1. Chapman M.D., Briza P. Molecular approaches to allergen standardization. Curr Allergy Asthma Rep. 2012;12:478–484. - PubMed
    1. Jutel M., Agache I., Bonini S., Burks W., Calderon M., Canonica W., et al. International consensus on allergen immunotherapy II: mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016;137:358–368. - PubMed
    1. Burks A.W., Calderon M.A., Casale T., Cox L., Demoly P., Jutel M., et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013;131:1288–1296. [e3] - PubMed

LinkOut - more resources